PT1158992E - Utilizacao do xenon para preparar uma preparacao farmaceutica para tratamento de neurointoxicacoes - Google Patents

Utilizacao do xenon para preparar uma preparacao farmaceutica para tratamento de neurointoxicacoes

Info

Publication number
PT1158992E
PT1158992E PT00910789T PT00910789T PT1158992E PT 1158992 E PT1158992 E PT 1158992E PT 00910789 T PT00910789 T PT 00910789T PT 00910789 T PT00910789 T PT 00910789T PT 1158992 E PT1158992 E PT 1158992E
Authority
PT
Portugal
Prior art keywords
neuroxtoxicacoes
xenon
preparing
treatment
pharmaceutical preparation
Prior art date
Application number
PT00910789T
Other languages
English (en)
Inventor
Christian Petzelt
Wolfgang J Kox
Original Assignee
Aga Aktiebolag Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7900688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1158992(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aga Aktiebolag Publ filed Critical Aga Aktiebolag Publ
Publication of PT1158992E publication Critical patent/PT1158992E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT00910789T 1999-03-11 2000-03-08 Utilizacao do xenon para preparar uma preparacao farmaceutica para tratamento de neurointoxicacoes PT1158992E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19910986A DE19910986C2 (de) 1999-03-11 1999-03-11 Verwendung von Xenon bei der Behandlung von Neurointoxikationen

Publications (1)

Publication Number Publication Date
PT1158992E true PT1158992E (pt) 2004-01-30

Family

ID=7900688

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00910789T PT1158992E (pt) 1999-03-11 2000-03-08 Utilizacao do xenon para preparar uma preparacao farmaceutica para tratamento de neurointoxicacoes

Country Status (29)

Country Link
US (3) US6559190B1 (pt)
EP (1) EP1158992B2 (pt)
JP (1) JP4954373B2 (pt)
KR (1) KR100674407B1 (pt)
CN (1) CN1170544C (pt)
AR (1) AR022886A1 (pt)
AT (1) ATE248599T1 (pt)
AU (1) AU757361B2 (pt)
BG (1) BG105889A (pt)
BR (1) BR0010456A (pt)
CA (1) CA2367136C (pt)
CZ (1) CZ302864B6 (pt)
DE (2) DE19910986C2 (pt)
DK (1) DK1158992T3 (pt)
EE (1) EE200100480A (pt)
ES (1) ES2206202T5 (pt)
HK (1) HK1048073B (pt)
HU (1) HUP0201393A3 (pt)
IL (2) IL145177A0 (pt)
MD (1) MD2935C2 (pt)
NO (1) NO20014379L (pt)
PL (1) PL202941B1 (pt)
PT (1) PT1158992E (pt)
RS (1) RS49756B (pt)
RU (1) RU2246949C2 (pt)
SI (1) SI1158992T1 (pt)
SK (1) SK285111B6 (pt)
WO (1) WO2000053192A1 (pt)
ZA (1) ZA200107291B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913677D0 (en) 1999-06-11 1999-08-11 Imperial College Formulation
US6653354B2 (en) 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
DE10045829A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Volatile Anästhesiemittel mit Xenon
DE10054563A1 (de) * 2000-11-03 2002-05-16 Messer Griesheim Gmbh Verfahren und Vorrichtung zur Betonherstellung
US20020102211A1 (en) * 2000-12-07 2002-08-01 Renshaw Perry F. Use of magnetic resonance imaging in diagnosis of membrane fluidity-related disorders
GB0209998D0 (en) † 2002-05-01 2002-06-12 Protexeon Ltd Use
GB0210021D0 (en) * 2002-05-01 2002-06-12 Air Prod & Chem Ultrasonic gas analyser
AU2003246415A1 (en) * 2002-06-12 2003-12-31 Messer Griesheim Gmbh Cerebral protection with a gas comprising xenon
US20050255169A1 (en) * 2002-07-05 2005-11-17 Messer Griesheim Adjuvant containing xenon
GB0218153D0 (en) * 2002-08-05 2002-09-11 Ic Innovations Ltd An analgesic agent for newborn or retal subjects
US7681572B2 (en) 2002-08-20 2010-03-23 Aga Ab Method and devices for administration of therapeutic gases
US7337776B2 (en) 2002-08-20 2008-03-04 Aga Ab Methods for easing pain and anxiety from atrial or ventricular defibrillation
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
EP1670489B1 (en) * 2003-10-10 2007-12-12 Protexeon Limited Use of xenon with hypothermia for treating neonatal asphyxia
US20080031971A1 (en) * 2003-10-21 2008-02-07 Aga Ab Use Of Xenon For The Prevention Of Programmed Cell Death
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
EP1552840A1 (en) * 2004-01-07 2005-07-13 Aga Ab Use of a xenon/carbon monoxide mixture for the protection of cells
US7070005B2 (en) * 2004-02-10 2006-07-04 Planetair Turf Products, Llc Soil aerator assembly
EP1830856B1 (en) * 2004-08-02 2012-04-18 John W. Olney Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems
WO2007075100A1 (en) * 2005-12-27 2007-07-05 Zakrytoe Aktsionernoe Obshchestvo 'atom-Med Center' Method for treating drug dependence
EP1980260A1 (en) * 2007-04-10 2008-10-15 Nicholas Peter Franks Use of hyperbaric conditions to provide neuroprotection
CA2685446A1 (en) * 2007-04-30 2008-11-06 Nnoxe Pharmaceutiques Inc. Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
ITMI20071031A1 (it) * 2007-05-22 2008-11-23 Acetilene & Deriv Ati Siad Spa Uso di xenon per la protezione di organi da danno ischemico
WO2010035074A1 (en) * 2008-09-25 2010-04-01 Nnoxe Pharmaceutiques Inc Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents
FR2952305B1 (fr) 2009-11-10 2012-04-27 Air Liquide Medicament inhalable a base de xenon pour traiter ou pour prevenir les dyskinesies
WO2011081612A1 (ru) * 2009-12-31 2011-07-07 Bondarenko Vitaliy Leonidovich Применение криптона или ксенона в качестве противовирусного средства
FR2956323B1 (fr) 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
FR2960779A1 (fr) 2010-06-08 2011-12-09 Air Liquide Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques
FR2964036B1 (fr) 2010-08-24 2013-04-12 Air Liquide Medicament gazeux inhalable a base de krypton pour le traitement des neuro-intoxications
WO2012109107A1 (en) 2011-02-07 2012-08-16 Rich Products Corporation Method for preserving cells and cell cultures
FR2975597B1 (fr) * 2011-05-24 2013-12-27 Air Liquide Utilisation de neon pour le traitement des neuro-intoxications, notamment des maladies enurodegeneratives et demyelinisantes
WO2013049118A1 (en) 2011-09-26 2013-04-04 Rich Products Corporation Method for living tissue preservation
RU2489154C1 (ru) * 2012-05-31 2013-08-10 Сергей Александрович Наумов Способ лечения вирусных гепатитов
CN103565745A (zh) 2012-08-10 2014-02-12 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
FR2996457B1 (fr) 2012-10-09 2019-11-29 L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996459B1 (fr) 2012-10-09 2015-02-06 Air Liquide Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996458B1 (fr) 2012-10-09 2015-02-27 Air Liquide Utilisation de xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
WO2014093277A1 (en) 2012-12-11 2014-06-19 The Mclean Hospital Corporation Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
CN105228591B (zh) 2013-03-15 2019-08-13 德克萨斯州大学系统董事会 富含稀有气体的液体及其制备和使用方法
FR3007983B1 (fr) * 2013-07-08 2015-06-26 Air Liquide Association de xenon et d'un antagoniste des recepteurs nmda pour lutter contre une maladie neurodegenerative
FR3022456B1 (fr) * 2014-06-20 2016-07-15 Air Liquide Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central
FR3027226B1 (fr) * 2014-10-17 2017-12-08 L'air Liquide Sa Pour L'etude Et L'exploitation Des Procedes Georges Claude Medicament pour traiter une maladie liee a un dysfonctionnement de la transmission synaptique dopaminergique
CN107921008A (zh) * 2015-06-23 2018-04-17 诺比利斯治疗学公司 使用惰性气体组合物的治疗性免疫调节
US20180318338A1 (en) * 2015-11-09 2018-11-08 The Mclean Hospital Corporation Methods and compositions for the prevention of suicide, homicide and self-harming behaviors
US20170341980A1 (en) * 2016-05-31 2017-11-30 Noblis Therapeutics, Inc. Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity
US10485825B2 (en) * 2016-08-29 2019-11-26 Nobilis Therapeutics, Inc. Prevention of pregnancy complications by noble gas administration
EP3532073A4 (en) * 2016-10-31 2020-09-02 Nobilis Therapeutics, Inc. TREATMENT OF ANXIETY DISORDER AND INCREASED ANTI-ANXIETY INTERVENTIONS BY ADMINISTRATION OF MIXTURES CONTAINING A NOBLE GAS
CN107569509B (zh) * 2017-02-22 2018-09-21 滨州医学院 氙或氙气体混合物在制备治疗癫痫的制剂中的用途
CN108986622A (zh) * 2018-08-16 2018-12-11 广州迈普再生医学科技股份有限公司 一种颅内血肿微创穿刺清除术培训装置及其制备方法
RU2712804C1 (ru) * 2018-08-29 2020-01-31 Жовнерчук Инна Юрьевна Способ коррекции функционального состояния человека в замкнутом пространстве

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5228434A (en) * 1991-07-16 1993-07-20 Praxair Technology, Inc. Mixture for anesthesia
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
US5357959A (en) * 1993-04-16 1994-10-25 Praxair Technology, Inc. Altered dipole moment magnetic resonance imaging method
US5846556A (en) * 1996-06-14 1998-12-08 Brooks; Bradley S. Inhalant for reducing stress and method of use
IT1286058B1 (it) * 1996-10-29 1998-07-07 Siad Societa Italiana Acetilen Procedimento e apparecchiatura per la purificazione e recupero dello xeno e altri gas nobili in sistemi anestetici
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist

Also Published As

Publication number Publication date
US6559190B1 (en) 2003-05-06
HK1048073A1 (en) 2003-03-21
CA2367136A1 (en) 2000-09-14
PL350618A1 (en) 2003-01-27
SK12792001A3 (sk) 2002-07-02
IL145177A0 (en) 2002-06-30
HUP0201393A3 (en) 2002-10-28
US8143317B2 (en) 2012-03-27
SI1158992T1 (en) 2004-02-29
RS49756B (sr) 2008-04-04
KR20010108338A (ko) 2001-12-07
CZ20013234A3 (cs) 2002-06-12
DE60004974T3 (de) 2012-06-28
IL145177A (en) 2006-10-31
KR100674407B1 (ko) 2007-01-26
BR0010456A (pt) 2002-08-27
ES2206202T5 (es) 2012-05-22
DE60004974D1 (de) 2003-10-09
US20030180375A1 (en) 2003-09-25
MD2935B2 (en) 2005-12-31
SK285111B6 (sk) 2006-06-01
EE200100480A (et) 2002-12-16
CA2367136C (en) 2008-05-13
DK1158992T3 (da) 2003-12-29
AR022886A1 (es) 2002-09-04
HUP0201393A2 (en) 2002-09-28
ES2206202T3 (es) 2004-05-16
ATE248599T1 (de) 2003-09-15
AU757361B2 (en) 2003-02-20
AU3287500A (en) 2000-09-28
HK1048073B (zh) 2005-06-03
YU65401A (sh) 2004-07-15
CN1359296A (zh) 2002-07-17
PL202941B1 (pl) 2009-08-31
MD20010349A (en) 2002-02-28
DE60004974T2 (de) 2004-07-22
JP2002538209A (ja) 2002-11-12
NO20014379L (no) 2001-11-07
DE19910986C2 (de) 2001-06-07
RU2246949C2 (ru) 2005-02-27
US20070110821A1 (en) 2007-05-17
NO20014379D0 (no) 2001-09-10
JP4954373B2 (ja) 2012-06-13
DE19910986A1 (de) 2000-09-21
EP1158992A1 (en) 2001-12-05
MD2935C2 (ro) 2006-08-31
ZA200107291B (en) 2003-02-26
EP1158992B2 (en) 2012-02-01
CN1170544C (zh) 2004-10-13
EP1158992B1 (en) 2003-09-03
BG105889A (bg) 2002-04-30
WO2000053192A1 (en) 2000-09-14
CZ302864B6 (cs) 2011-12-21

Similar Documents

Publication Publication Date Title
PT1158992E (pt) Utilizacao do xenon para preparar uma preparacao farmaceutica para tratamento de neurointoxicacoes
HUP0203437A3 (en) Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
PT1090574E (pt) Dispositivo para a extraccao de uma substancia para a preparacao de uma bebida
HUP0301242A3 (en) Controlled release drug dosage form
AR028574A1 (es) Mascara de administracion de farmacos para animales
IL213806A0 (en) Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
EP1221976A4 (en) IFN-GAMA IN LOW DOSAGE FOR TREATING DISEASES
EP1207852A4 (en) ORAL PHARMACEUTICALS WITH TAXED RELEASE FOR ORAL ADMINISTRATION
EE04683B1 (et) A-grupi streptogramiinide derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
HUP0301317A3 (en) Use of neuroprotective 7-beta-hydroxysteroids for preparation of pharmaceutical compositions
HUP0201405A3 (en) Pharmaceutical composition for therapeutic use of melatonin
HK1046140A1 (zh) 固體藥劑
EE200100539A (et) Prukalopriidi vesilahus suukaudseks manustamiseksning selle valmistamismeetod
HUP0302291A3 (en) Sulfonamide derivatives, process for their preparation and their use for preparation of pharmaceutical compositions
BR9802536A (pt) Método para anestesiar um paciente humano antes de cirurgias
HUP0301134A3 (en) Use of 7-hydroxyepiandrosterone having neuroprotective activity for preparing pharmaceutical compositions
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
HUP0202347A2 (en) N-acylated pseudomycin analogs, process for their preparation, pharmaceutical compositions comprising thereof and their use
HUP0204547A3 (en) Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms